Skip to main content
Clinical Trials/NCT04905849
NCT04905849
Terminated
Not Applicable

Enhancing Cognitive Control Abilities Using Mobile Technology in a Senior Living Community

University of California, San Francisco1 site in 1 country12 target enrollmentMay 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aging
Sponsor
University of California, San Francisco
Enrollment
12
Locations
1
Primary Endpoint
Number of Participants Who Attempted to Complete the Adaptive Cognitive Evaluation (ACE) From Baseline at 6 Weeks
Status
Terminated
Last Updated
10 months ago

Overview

Brief Summary

The goal of this study is to test the feasibility of launching a personalized digital health assessment and remediation program for the older adults in senior living communities based upon an initial characterization of these abilities. Evidence of feasibility here using these unique methodological approaches would provide empirical evidence supporting the basis for a larger-scale implementation of such digital health technologies into less controlled senior settings.

Registry
clinicaltrials.gov
Start Date
May 1, 2021
End Date
December 1, 2022
Last Updated
10 months ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Must be living at a Senior Living Community
  • have own iPad and/or smartphone,
  • native-English speaker.
  • Participation across a spectrum of cognitive abilities is desired for this study, specifically for older adults in a community setting.

Exclusion Criteria

  • Do not have any physical or cognitive limitations that would clearly prevent them from utilizing these applications as intended

Outcomes

Primary Outcomes

Number of Participants Who Attempted to Complete the Adaptive Cognitive Evaluation (ACE) From Baseline at 6 Weeks

Time Frame: At Baseline and post intervention at the 6 week mark

ACE is a custom mobile cognitive health assessment battery that presents paradigms typically used in standard cognitive neuroscience laboratories. Here the investigators will assess a measure of (1) Attention and (2) Working memory in the ACE software.

Secondary Outcomes

  • Mean Performance on the Everyday Cognition Scale (ECog) From Baseline at 6 Weeks(At Baseline and post intervention at the 6 week mark)
  • Mean Change on Cognitive Failures Questionnaire (CFQ) From Baseline at 6 Weeks(At Baseline and post intervention at the 6 week mark)
  • Mean Change on General Health and Well-being (SF-36) From Baseline at 6 Weeks(At Baseline and post intervention at the 6 week mark)

Study Sites (1)

Loading locations...

Similar Trials